2009 DU flashback: (on the partial origins of the Health Care Deal) Obama on Drugs: 98% Cheney?

http://www.democraticunderground.com/discuss/duboard.php?az=view_all&address=389x6295096

Obama on Drugs: 98% Cheney?
Greg Palast

http://www.huffingtonpost.com/greg-palast/obama-on-drugs-98-cheney_b_258209.html

<edit>

ALERT

Now it's Let's Make a Deal with hospital lobbyists.

First, the President was caught with his principals down, cutting a scuzzy back-room deal with pharmaceutical lobbyist Billy Tauzin to limit drug price savings to just 2% over 10 years (see attached, "Obama on Drugs: 98% Cheney?&quot , the New York Times today reports that another deal was sealed by lobbyist Chip Kahn of the American Hospital Association.

Here are the numbers they don't want you to see: Hospitals will be allowed to hike their prices and revenues by six trillion dollars ($5,853 billion) over the next ten years, only $155 billion less than they had projected before the Obama "reform."

In all, the Obama back-room deal will "reduce" our $26 trillion total hospital bill over the next decade by one-half of one percent.

Once again, the lobbyists got the gold mine, the public got the shaft.

Say it ain't so, Mr. President.

<edit>

Cheney's secret meetings with lobbyists and industry big-shots were creepy and nasty and evil.

But the Obama crew's secret meetings with lobbyists and industry bigshots were, the President assures us, in the public interest.

We know Cheney's secret confabs were shady and corrupt because Cheney scowled out the side of his mouth.

Obama grins in your face.

more...

------------------------------------------------------------


Internal Memo Confirms Big Giveaways In White House Deal With Big Pharma

First Posted: 08-13-09 11:10 AM | Updated: 08-13-09 11:15 AM

http://www.huffingtonpost.com/2009/08/13/internal-memo-confirms-bi_n_258285.html

A memo obtained by the Huffington Post confirms that the White House and the pharmaceutical lobby secretly agreed to precisely the sort of wide-ranging deal that both parties have been denying over the past week.

The memo, which according to a knowledgeable health care lobbyist was prepared by a person directly involved in the negotiations, lists exactly what the White House gave up, and what it got in return.

It says the White House agreed to oppose any congressional efforts to use the government's leverage to bargain for lower drug prices or import drugs from Canada -- and also agreed not to pursue Medicare rebates or shift some drugs from Medicare Part B to Medicare Part D, which would cost Big Pharma billions in reduced reimbursements.

In exchange, the Pharmaceutical Researchers and Manufacturers Association (PhRMA) agreed to cut $80 billion in projected costs to taxpayers and senior citizens over ten years. Or, as the memo says: "Commitment of up to $80 billion, but not more than $80 billion."




snip
---------------------------

http://www.nytimes.com/2009/08/06/health/policy/06insure.html?_r=1

White House Affirms Deal on Drug Cost


By DAVID D. KIRKPATRICK

Published: August 5, 2009


WASHINGTON — Pressed by industry lobbyists, White House officials on Wednesday assured drug makers that the administration stood by a behind-the-scenes deal to block any Congressional effort to extract cost savings from them beyond an agreed-upon $80 billion. Drug industry lobbyists reacted with alarm this week to a House health care overhaul measure that would allow the government to negotiate drug prices and demand additional rebates from drug manufacturers.

In response, the industry successfully demanded that the White House explicitly acknowledge for the first time that it had committed to protect drug makers from bearing further costs in the overhaul. The Obama administration had never spelled out the details of the agreement.

“We were assured: ‘We need somebody to come in first. If you come in first, you will have a rock-solid deal,’ ” Billy Tauzin, the former Republican House member from Louisiana who now leads the pharmaceutical trade group, said Wednesday. “Who is ever going to go into a deal with the White House again if they don’t keep their word? You are just going to duke it out instead.”

A deputy White House chief of staff, Jim Messina, confirmed Mr. Tauzin’s account of the deal in an e-mail message on Wednesday night. “The president encouraged this approach,” Mr. Messina wrote. “He wanted to bring all the parties to the table to discuss health insurance reform.”

The new attention to the agreement could prove embarrassing to the White House, which has sought to keep lobbyists at a distance, including by refusing to hire them to work in the administration. The White House commitment to the deal with the drug industry may also irk some of the administration’s Congressional allies who have an eye on drug companies’ profits as they search for ways to pay for the $1 trillion cost of the health legislation.